2cureX Webcast and Q&A – 2cureX’s Executive Management and Board of Directors are pleased to invite you to a webcast on 24 September 2024 at 20:00 CET.
Commentary on Q2 2023 report – Infront Direkt Studios will host an interview with CEO Fernando Andreu regarding the results presented in the Q2 2023 report.
All things permitting, we look forward to seeing you all at ESMO GI again this summer. We will be there in Barcelona in person from 28 June – 1 July. More details to follow.
Commentary on Q1 2023 report – Infront Direkt Studios will host an interview with CEO Fernando Andreu regarding the results presented in the Q1 2023 report.
IndiTreat®’s Finnish Distributor Algol Diagnostics present at congress next week. On May 12, our IndiTreat® distributor in Finland, Algol Diagnostics, will be participating in the Oncology Society’s GI Cooperation congress.